Last reviewed · How we verify

NCT05442268

Duloxetine for Postoperative Analgesia After Modified Radical Mastectomy

Status unknown NA Last updated 20 July 2022
What this trial tests

NA trial testing Acetaminophen group in Modified Radical Mastectomy in 40 participants. Status unknown.

Timeline
16 July 2022
Primary endpoint
31 January 2023
31 January 2023

Quick facts

Lead sponsorTanta University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment40
Start date16 July 2022
Primary completion31 January 2023
Estimated completion31 January 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 18 to 60, female only, with Modified Radical Mastectomy or Postoperative Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the role of duloxetine in controlling pain after radical mastectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Acetaminophen group

Trials testing the same drug.

Other recruiting trials for Modified Radical Mastectomy

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05442268.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing